Multidimensional Assessment of response to treatment of spontaneous and osteoporosis-induced corticosteroids to help an Administration Oral Bisphosphonate In The Sick Holders of A Muscular Dystrophy severe.Évaluation Multidimensionnelle de la réponse au Traitement de l'ostéoporose spontanée et Induite Par Les corticostéroïdes à l'Aide d'un Bisphosphonate à Administration Orale Chez Des Malades Porteurs d'Une Dystrophie Musculaire sévère.

Trial Profile

Multidimensional Assessment of response to treatment of spontaneous and osteoporosis-induced corticosteroids to help an Administration Oral Bisphosphonate In The Sick Holders of A Muscular Dystrophy severe.Évaluation Multidimensionnelle de la réponse au Traitement de l'ostéoporose spontanée et Induite Par Les corticostéroïdes à l'Aide d'un Bisphosphonate à Administration Orale Chez Des Malades Porteurs d'Une Dystrophie Musculaire sévère.

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 May 2015

At a glance

  • Drugs Risedronic acid (Primary)
  • Indications Osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top